OrthoPediatrics Corp. (KIDS) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
KIDS, 15.87$ (piyasa değeri 402M) fiyatla Healthcare işi olan OrthoPediatrics Corp.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 5 Şub 2026OrthoPediatrics Corp. (KIDS) Sağlık ve Boru Hattı Genel Bakışı
OrthoPediatrics Corp. (KIDS) pioneers anatomically appropriate orthopedic solutions for children, capturing a specialized market with innovative implants and devices, strong gross margins of 71.7%, and a commitment to addressing unmet needs in pediatric care, despite current profitability challenges.
Yatırım Tezi
OrthoPediatrics presents a notable research candidate due to its focus on the underserved pediatric orthopedic market. The company's specialized product portfolio and commitment to innovation drive revenue growth and market share gains. While the company currently operates at a loss, indicated by a P/E ratio of -8.52 and a profit margin of -20.1%, its high gross margin of 71.7% demonstrates the potential for future profitability as the company scales its operations and achieves greater efficiency. Key growth catalysts include expanding its product offerings, penetrating new geographic markets, and increasing adoption of its products among pediatric orthopedic surgeons. The company's strong market position and dedication to addressing the unique needs of pediatric patients make it an attractive investment for those seeking exposure to the growing medical device market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Gross margin of 71.7% indicates strong pricing power and efficient manufacturing processes.
- Focus on the underserved pediatric orthopedic market provides a niche advantage.
- Comprehensive product portfolio addresses a wide range of pediatric orthopedic conditions.
- Global market reach allows for expansion into new geographic regions.
- Dedicated to innovation and patient-centric design, driving product adoption and market leadership.
Rakipler & Benzerleri
Güçlü Yönler
- Specialized product portfolio for pediatric orthopedics.
- Strong brand reputation and relationships with surgeons.
- High gross margin of 71.7%.
- Global market reach.
Zayıflıklar
- Currently unprofitable with a negative P/E ratio.
- Relatively small market capitalization.
- Dependence on a niche market.
- Limited financial resources compared to larger competitors.
Katalizörler
- Upcoming: New product launches in the trauma and deformity correction segment.
- Ongoing: Expansion into new geographic markets, particularly in Asia and Latin America.
- Ongoing: Increasing adoption of existing products through surgeon training programs.
- Ongoing: Strategic partnerships with hospitals and healthcare systems.
Riskler
- Potential: Product liability claims related to orthopedic implants.
- Potential: Regulatory changes affecting the approval and reimbursement of medical devices.
- Ongoing: Competition from larger medical device companies with greater resources.
- Ongoing: Economic downturns affecting healthcare spending and demand for elective procedures.
Büyüme Fırsatları
- Expanding Product Portfolio: OrthoPediatrics can drive growth by developing and launching new products that address unmet needs in the pediatric orthopedic market. This includes expanding its offerings in areas such as sports medicine, trauma, and deformity correction. The market for pediatric orthopedic devices is estimated to be worth several billion dollars, providing ample opportunity for growth. Timeline: Ongoing.
- Geographic Expansion: OrthoPediatrics can expand its global footprint by entering new geographic markets, particularly in developing countries where access to specialized pediatric orthopedic care is limited. This includes establishing distribution partnerships, building local sales teams, and obtaining regulatory approvals. The global market for pediatric orthopedic devices is expected to grow significantly in the coming years, driven by increasing awareness and demand. Timeline: Ongoing.
- Strategic Acquisitions: OrthoPediatrics can accelerate its growth by acquiring complementary businesses or technologies in the pediatric orthopedic space. This includes acquiring companies with innovative products, established distribution networks, or specialized expertise. Strategic acquisitions can help OrthoPediatrics expand its product portfolio, enter new markets, and strengthen its competitive position. Timeline: Ongoing.
- Increased Adoption of Existing Products: OrthoPediatrics can drive growth by increasing the adoption of its existing products among pediatric orthopedic surgeons. This includes providing training and education programs, conducting clinical studies to demonstrate the efficacy of its products, and building strong relationships with key opinion leaders. Increased adoption of existing products can lead to significant revenue growth and market share gains. Timeline: Ongoing.
- Partnerships with Hospitals and Healthcare Systems: OrthoPediatrics can establish strategic partnerships with hospitals and healthcare systems to promote the use of its products and services. This includes offering bundled solutions, providing customized training programs, and participating in joint research initiatives. Partnerships with hospitals and healthcare systems can help OrthoPediatrics gain access to a wider patient population and increase its market share. Timeline: Ongoing.
Fırsatlar
- Expanding product portfolio to address unmet needs.
- Entering new geographic markets.
- Acquiring complementary businesses or technologies.
- Increasing adoption of existing products through education and training.
Tehditler
- Competition from larger medical device companies.
- Regulatory changes and reimbursement pressures.
- Product liability claims.
- Economic downturns affecting healthcare spending.
Rekabet Avantajları
- Specialized product portfolio tailored for pediatric patients.
- Strong relationships with pediatric orthopedic surgeons.
- Proprietary technology and intellectual property.
- High barriers to entry due to regulatory requirements and specialized expertise.
KIDS Hakkında
Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics Corp. (KIDS) is a medical device company dedicated to transforming the lives of children with orthopedic conditions. Recognizing the unique anatomical and physiological differences between children and adults, OrthoPediatrics designs, develops, and markets a comprehensive range of implants and devices tailored specifically for pediatric patients. The company's product portfolio includes solutions for trauma and deformity correction, scoliosis procedures, and sports medicine applications. Key product lines include PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. OrthoPediatrics serves a global market, focusing on pediatric orthopedic surgeons and caregivers who seek specialized solutions for their young patients. The company's commitment to innovation and patient-centric design has positioned it as a leader in the pediatric orthopedic market, addressing a critical unmet need in the medical device industry.
Ne Yaparlar
- Designs anatomically appropriate implants and devices for children.
- Develops solutions for trauma and deformity correction.
- Offers scoliosis procedures for spinal deformity treatment.
- Provides sports medicine products tailored for pediatric patients.
- Serves pediatric orthopedic surgeons and caregivers.
- Markets products in the United States and internationally.
İş Modeli
- Develops and manufactures specialized orthopedic implants and devices for children.
- Sells products directly to hospitals and orthopedic surgeons.
- Generates revenue through product sales and related services.
- Focuses on innovation and patient-centric design to drive product adoption.
Sektör Bağlamı
The medical device industry is experiencing steady growth, driven by technological advancements, an aging population, and increasing demand for minimally invasive procedures. The pediatric orthopedic market, in particular, represents a significant opportunity due to the unique anatomical and physiological needs of children. OrthoPediatrics competes with larger medical device companies that may offer some pediatric products, but its exclusive focus on pediatric orthopedics provides a competitive advantage. The company's commitment to innovation and patient-centric design positions it well to capitalize on the growing demand for specialized pediatric orthopedic solutions.
Kilit Müşteriler
- Pediatric orthopedic surgeons
- Hospitals and medical centers
- Caregivers of children with orthopedic conditions
Finansallar
Grafik & Bilgi
OrthoPediatrics Corp. (KIDS) hisse senedi fiyatı: $15.87 (+0.67, +4.41%)
Son Haberler
-
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Brokerages
defenseworld.net · 29 Mar 2026
-
Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know
zacks.com · 24 Mar 2026
-
POTTERY BARN KIDS AND POTTERY BARN TEEN LAUNCH EXCLUSIVE COLLABORATION WITH HILL HOUSE HOME
businesswire.com · 24 Mar 2026
-
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?
zacks.com · 3 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
KIDS için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
KIDS için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, KIDS'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Brokerages
Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know
POTTERY BARN KIDS AND POTTERY BARN TEEN LAUNCH EXCLUSIVE COLLABORATION WITH HILL HOUSE HOME
OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?
Yatırımcılar OrthoPediatrics Corp. (KIDS) Hakkında Ne Soruyor
KIDS için değerlendirilmesi gereken temel faktörler nelerdir?
OrthoPediatrics Corp. (KIDS) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Specialized product portfolio for pediatric orthopedics.. İzlenmesi gereken birincil risk: Potential: Product liability claims related to orthopedic implants.. Bu bir finansal tavsiye değildir.
KIDS MoonshotScore'u nedir?
KIDS şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
KIDS verileri ne sıklıkla güncellenir?
KIDS fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler KIDS hakkında ne diyor?
KIDS için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
KIDS'a yatırım yapmanın riskleri nelerdir?
KIDS için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Product liability claims related to orthopedic implants.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
KIDS'ın P/E oranı nedir?
KIDS için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için KIDS'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
KIDS aşırı değerli mi, yoksa düşük değerli mi?
OrthoPediatrics Corp. (KIDS)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
KIDS'ın temettü verimi nedir?
OrthoPediatrics Corp. (KIDS) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Stock data pending update.
- Financial data based on available information and may be subject to change.